Long-term lithium treatment attenuated the hypokinetic effect of reserpine in a patient with tardive dyskinesia. In rats, prophylactic lithium administration inhibits reserpine-induced dopamine depletion in the brain. These data indicate that lithium may limit the therapeutic efficacy of reserpine in tardive dyskinesia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ana.410130617 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!